west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "巨细胞" 68 results
  • 儿童Wiskott-Aldrich综合征合并巨细胞病毒性视网膜炎一例

    Release date:2019-07-16 05:35 Export PDF Favorites Scan
  • Multi slice CT spiral and MRI Performance of Spinal Giant Cell Tumor (6 Cases’ Reports)

    目的:明确脊柱骨巨细胞瘤的多层螺旋CT、MRI表现。方法:回顾性分析经病理证实的脊柱骨巨细胞瘤6例(男5例,女1例,年龄21~40岁,平均32岁)。6例CT检查,3例有MRI检查。结果:发生于胸椎3例,腰椎1例,骶椎2例。CT主要表现为膨胀性溶骨性破坏和较大软组织肿块;MRI表现T1加权成像为低等信号,T2加权成像为高低混杂信号特点,可显示瘤内坏死、囊变、出血等。结论:脊柱骨巨细胞瘤具有侵袭性强、生长活跃、易复发等特点,结合CT、MRI检查可对该病做出及时诊断,且对临床分期、手术方案制订及术后定期随访有重要价值。

    Release date:2016-09-08 10:01 Export PDF Favorites Scan
  • CLINICAL STUDIES ON EFFECT OF BONE CEMENT FILLING ON ARTICULAR CARTILAGE OF THE KNEE AFTER CURETTAGE OF GIANT CELL TUMOR

    ObjectiveTo evaluate the effect of bone cement filling on articular cartilage injury after curettage of giant cell tumor around the knee. MethodsFifty-three patients with giant cell tumor who accorded with the inclusion criteria were treated between January 2000 and December 2011, and the cl inical data were retrospectively analyzed. There were 30 males and 23 females, aged 16-69 years (mean, 34.2 years). The lesion located at the distal femur in 28 cases and at the proximal tibia in 25 cases. According to Campanacci grade, there were 6 patients at grade I, 38 at grade Ⅱ, and 9 at grade Ⅲ. Of 53 patients, 42 underwent curettage followed by bone cement fill ing, and 11 received curettage followed by bone grafts in the subchondral bony area and bone cement fill ing. Two groups were divided according to whether secondary osteoarthritis occurred or not during postoperative follow-up. The gender, age, lesion site, the subchondral residual bone thickness, tumor cross section, preoperative Campanacci grade, subchondral bone graft, and Enneking function score were compared between 2 groups, and multivariate logistic regression analysis was done. ResultsAll incisions healed by first intention. The average follow-up time was 65 months (range, 23-158 months). Of 53 cases, 37 (69.8%) had no osteoarthritis, and 16 (30.2%) had secondary osteoarthritis. Three cases (5.7%) recurred during the follow-up period. Univariate logistic regression analysis showed no significant difference in gender, age, lesion site, and Campanacci grade between 2 groups (P>0.1); difference was significant in the subchondral residual bone thickness, tumor cross section, Enneking function score, and subchondral bone graft (P<0.1). The multivariate logistic regression analysis showed that the decreased subchondral residual bone thickness, the increased tumor cross section, and no subchondral bone graft are the risk factors of postoperative secondary osteoarthritis (P<0.05). ConclusionCurettage of giant cell tumor around the knee followed by bone cement filling can increase the damage of cartilage, and subchondral bone graft can delay or reduce cartilage injury.

    Release date: Export PDF Favorites Scan
  • Activity of curcumin against human cytomegalovirus infection in vitro

    This study aimed to investigate the effect of curcumin (Cur) against human cytomegalovirus (HCMV) in vitro. Human embryonic lung fibroblasts were cultured in vitro. The tetrazolium salt (MTS) method was used to detect the effects of Cur on cell viability. The cells were divided into control group, HCMV group, HCMV + (PFA) group and HCMV + Cur group in this study. The cytopathic effect (CPE) of each group was observed by plaque test, then the copy number of HCMV DNA in each group was detected by quantitative polymerase chain reaction (qPCR), and the expression of HCMV proteins in different sequence was detected by Western blot. The results showed that when the concentration of Cur was not higher than 15 μmol/L, there was no significant change in cell growth and viability in the Cur group compared with the control group (P>0.05). After the cells were infected by HCMV for 5 d, the cells began to show CPE, and the number of plaques increased with time. Pretreatment with Cur significantly reduced CPE in a dose-dependent manner. After the cells were infected by HCMV, the DNA copy number and protein expression gradually increased in a time-dependent manner. Pretreatment with Cur significantly inhibited HCMV DNA copies and downregulate HCMV protein expression levels in a concentration-dependent manner, and the difference was statistically significant (P<0.05). In conclusion, Cur may exert anti-HCMV activity by inhibiting the replication of HCMV DNA and down-regulating the expression levels of different sequence proteins of HCMV. This study provides a new experimental basis for the development of anti-HCMV infectious drugs.

    Release date:2023-02-24 06:14 Export PDF Favorites Scan
  • 肾移植术后巨细胞病毒感染研究进展

    新型免疫抑制剂的使用使移植肾的存活率明显增加,但机会性感染的发生也随之增多。巨细胞病毒(CMV)感染是肾移植术后常见的并发症,除可引起直接损害外,还可对机体产生间接影响。现就肾移植术后巨细胞病毒感染的途径、危险因素、临床表现、实验室检查及防治进展作一综述。

    Release date:2016-09-08 09:13 Export PDF Favorites Scan
  • A PRELIMINARY CLINICAL OBSERVATION OF GIANT CELL TUMOR OF BONE TREATED BY ADRIAMYCINLOADED CHITOSAN DRUG BELIVERY SYSTEM

    In order to observe the curative effect and general reaction of locally used adriamycin (ADM)-loaded chitosan drug delivery system on giant cell tumor of bone after curettage. The cavities of 4 cases of giant cell tumor after curettage were filled with ADM-loaded chitosan drug delivery system with 4 times the dosage usually used for intravenous application. After operation, the concentration of ADM in plasma on the 1st, 2nd and 5th day, and the functions of liver and kidney on the 1st week, 1st month and 6th month were all investigated. The results were that the concentration of ADM in plasma was (143.05 +/- 27.55) ng/ml, (52.17 +/- 11.28) ng/ml and (4.25 +/- 3.07) ng/ml respectively, and the functions of liver and kidney were all normal in 6 months. After a follow-up of 7-19 months, no local or general reactions were observed and X-ray showed no recurrence. Therefore, it was concluded that the locally used ADM-loaded chitosan delivery system was safe and effective in treatment of giant cell tumor of bone after curettage.

    Release date:2016-09-01 11:07 Export PDF Favorites Scan
  • AN ANALYSIS ON FOLLOW-UP OF THE TREATMENT OF COMPLICATED GIANT CELL TUMOR OF BONE

    Objective To discuss the definition of complicated giant cell tumor of the bone and retrospectively analyze the treatment protocols and their therapeutic results so as to provide a clinical basis for reducing the postoperative recurrence of this kind of tumor. Methods From April 2001 to April 2005, 22patients (11 males and 11 females, aged 15-66 years) with complicated giant cell tumor of the bone were treated by the marginal or wide excision. The tumor was located in the distal femur in 10 patients, the proximal tibia in 5, theproximal femur in 2, the proximal humerus in 2, the hip bone in 2, and the distal radius in 1. The Campanicci′s grading system was used and the patients were grouped as follows: Grade Ⅱ in 4 patients, and Grade Ⅲ in 18. The functional results of the patients were assessed by the clinical examination. The reconstruction methods were used in the forms of osteoarticular allografting (14 patients) and total arthroplasty (8 patients). Results The analysis on the follow-up (6-48 months, averaged 23 months) of the 22 patients revealedthat the complicated factors were as follows: the tumor breaking through the cortex with an extraosseous mass; the tumor having pathologic fracture; the tumor representing more biologically-aggressive lesions; and the tumor having one or more local recurrences. Two patients (9%) had a local recurrence respectively 8 and 11 months after operation, but improved respectively by limb amputation and radiotherapy. Total arthroplasty achieved a better articular function than osteoarticular allografting. All the patients with osteoarticular allografts showed various degrees of the bone union of the allograft with the host bone. Conclusion The marginal or wide excision of this kind of complicated giant cell tumor of the bone combined withosteoarticular allograft or total arthroplasty can reduce the local recurrence of the tumor and achieve a certain degree of the articular motion function.

    Release date:2016-09-01 09:24 Export PDF Favorites Scan
  • VASCULARIZED FIBULAR COMBINED WITH ILIAC GRAFTING TO REPAIR BONE DEFECT AFTER TUMOR EXTENSIVE RESECTION FOR GIANT CELL TUMOR OF BONE AROUND KNEE

    Objective To study the method and effect of the vascularized fibular combined with iliac grafting after the tumor extensive resection for giant cell tumor of the bone around the knee. Methods Twenty-five patients with giantcell tumor of the bone around the knee were reviewed, who had been admitted to our hospital from October 1996 to November 2002, including 17 patients undergoing the fibular and iliac transplantation with the vessels anastomosed afterthe extensive excision of the bone tumor. By the surgicallystaged manner of Enneking, all the patients were grouped in the stage of ⅠA; by the Campanicci’s radioactive image staging, 11 patients were grouped in stage Ⅰ, 5 in stage Ⅱ, and 1 in stage Ⅲ; by the Jaffe’s pathological staging, 9 patients were grouped in stage Ⅰ, 7 in stage Ⅱ, and 1 in stage Ⅲ. Of the patients, 9 were treated by the vascularized fibular combined with iliac grafting in the proximal tibia after the tumor extensive resection, and 8 were treated by the distal femur reconstruction by the operation. The following items were also analyzed: postoperativeinfection, growth of the bone graft, rate of local recurrence, tumor metastasis, and bone death. The function of the knee joint was evaluated. Results According the follow-up of the 17 patients for 26-87 months (mean, 54 months), all thebone graft healed well within 75-120 days (mean, 93 days) after operation. Twopatients had a local recurrence and 3 had a mildly-narrowed joint. The flexion and extension function of the knee joint recovered, with a range of motion of thereconstructed distal femur of 80°-105° (mean, 96°) while the proximal tibia had a range of motion of 90-120° (mean, 110°). The functional outcome wasexcellent in 11 patients, good in 3 patients, fair in 1 patient, and bad in 2 patients,with a total satisfactory rate of 82.4%. Conclusion The vascularized fibular combined with iliac grafting after the tumor extensive resection to treat giant cell tumor of the bone around the knee has advantages of complete resection of the tumor and well-restored or reconstructed structure and function of the knee joint.

    Release date:2016-09-01 09:24 Export PDF Favorites Scan
  • 特制假体置换在邻关节骨巨细胞瘤治疗中的应用

    【摘 要】 目的 回顾性分析21 例骨巨细胞瘤患者行广泛切除、特制人工假体置换术,总结近关节部位骨巨细胞瘤切除后功能重建中使用特制假体的作用及效果。 方法 1999 年10 月- 2006 年8 月,对21 例骨巨细胞瘤患者行广泛切除、特制人工假体置换术。男12 例,女9 例;年龄19 ~ 42 岁,平均31.4 岁。肱骨上段4 例,肱骨远端1 例,髋骨体2 例,股骨近端2 例,股骨远端9 例,胫骨近端3 例。按Campanacci X 线分类:Ⅱ级9 例、Ⅲ级12 例。Enneking 外科分期均为3 期。 结果 患者术后切口均Ⅰ期愈合。21 例获随访8 ~ 70 个月。1 例髋骨体肿瘤术后14 个月因肺转移死亡,余患者无局部复发和转移,无骨折及假体松动。肢体功能按Enneking 肢体肌肉骨骼肿瘤外科治疗重建术后功能评估标准进行评估:ISOLS 综合评分优14 例,良4 例,差2 例,死亡1 例,优良率85.7%。 结论 特制假体置换治疗近关节部位骨巨细胞瘤能减少复发,提高患者生存质量,是一种疗效可靠的手术方法。

    Release date:2016-09-01 09:09 Export PDF Favorites Scan
  • Long-term effectiveness of vascularized fibula flap in radiocarpal joint reconstruction following excision of Campanacci grade Ⅲ giant cell tumor

    ObjectiveTo evaluate the long-term effectiveness of vascularized fibula flap in radiocarpal joint reconstruction following excision of Campanacci grade Ⅲ giant cell tumor (GCT) of distal radius.MethodsBetween December 2010 and December 2014, 10 patients with Campanacci grade Ⅲ GCT of distal radius were treated with en bloc excision and inradiocarpal joint reconstruction using vascularized fibula flap. They were 6 males and 4 females, with an average age of 39.9 years (range, 22-65 years). The disease duration was 1.5-6.0 months (mean, 2.6 months). The length of distal radius defect was 6.0-12.5 cm (mean, 8.4 cm) after en bloc excision of GCT. Vascularized fibula flap with inferior lateral genicular vessels were performed in 6 patients and with inferior lateral genicular vessels and peroneal vessels in 4 cases.ResultsAll incisions healed by first intention. All patients were followed up 4.4-8.3 years (mean, 6.0 years). There was no tumor recurrence during follow-up. At last follow-up, the mean ranges of motion of wrist joint were 55.0° (range, 25-85°) in extension, 26.5° (range, 15-40°) in flexion, 12.0° (range, 5-25°) in radial deviation, 19.6° (range, 10-30°) in ulnar deviation, 50.5° (range, 5-90°) in pronation, and 66.5° (range, 20-90°) in supination. The mean grip strength of effected wrist was 75% (range, 60%-85%) of the healthy wrist. The mean Musculoskeletal Tumor Society (MSTS) score was 82.7% (range, 75%-90%). X-ray films showed that the fibula flap healed at 12-16 weeks after operation (mean, 14.1 weeks) and there were 9 cases of radiological complications.ConclusionFor Campanacci grade Ⅲ GCT of distal radius, application of the vascularized fibula flap in radiocarpal joint reconstruction after en bloc excision of GCT can obtain good wrist function.

    Release date:2020-04-15 09:18 Export PDF Favorites Scan
7 pages Previous 1 2 3 ... 7 Next

Format

Content